Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kuball

Showing results (141-150 of 256) with videos related to

Pageof 26
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillationJürgen Kuball, Shu Fen Wen, Joachim Leissner, et al.
Leukemia|January 2, 2013
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemiaW Scheper, S van Dorp, S Kersting, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|May 30, 2023
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Best Practice & Research. Clinical Haematology|August 4, 2024
Celebrating the registration of 9.000 patients treated with CAR T cells in the EBMT registry: Collection of real-world data in the context of hematopoietic cellular therapiesChristian Chabannon, Annalisa Ruggeri, Silvia Montoto, et al.
Transplant Immunology|January 21, 2014
Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcomeM M Jöris, A C Lankester, P A von dem Borne, et al.
Blood Advances|February 10, 2022
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trialAnnoek E C Broers, Cornelis N de Jong, Katerina Bakunina, et al.
Bone Marrow Transplantation|May 4, 2020
Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMTZinaida Peric, Myriam Labopin, Christophe Peczynski, et al.
Bone Marrow Transplantation|March 18, 2018
Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinibLotte van der Wagen, Liane Te Boome, Marleen Schiffler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoireMatthias Wölfl, Alleluiah Rutebemberwa, Timothy Mosbruger, et al.
Pageof 26

Showing results (141-150 of 256) with videos related to

Sort By:
Pageof 26
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 15, 2002
Successful adenovirus-mediated wild-type p53 gene transfer in patients with bladder cancer by intravesical vector instillationJürgen Kuball, Shu Fen Wen, Joachim Leissner, et al.
Leukemia|January 2, 2013
γδT cells elicited by CMV reactivation after allo-SCT cross-recognize CMV and leukemiaW Scheper, S van Dorp, S Kersting, et al.
Bone Marrow Transplantation|February 23, 2016
Hematopoietic stem cell transplantation in Europe 2014: more than 40 000 transplants annuallyJ R Passweg, H Baldomero, P Bader, et al.
Bone Marrow Transplantation|May 30, 2023
Long-term outcome of second allogeneic hematopoietic stem cell transplantation (HSCT2) for primary graft failure in patients with acute leukemia in remission: A study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationArnon Nagler, Myriam Labopin, Ryszard Swoboda, et al.
Best Practice & Research. Clinical Haematology|August 4, 2024
Celebrating the registration of 9.000 patients treated with CAR T cells in the EBMT registry: Collection of real-world data in the context of hematopoietic cellular therapiesChristian Chabannon, Annalisa Ruggeri, Silvia Montoto, et al.
Transplant Immunology|January 21, 2014
Translating in vitro prediction of cytotoxic T cell alloreactivity to hematopoietic stem cell transplantation outcomeM M Jöris, A C Lankester, P A von dem Borne, et al.
Blood Advances|February 10, 2022
Posttransplant cyclophosphamide for prevention of graft-versus-host disease: results of the prospective randomized HOVON-96 trialAnnoek E C Broers, Cornelis N de Jong, Katerina Bakunina, et al.
Bone Marrow Transplantation|May 4, 2020
Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMTZinaida Peric, Myriam Labopin, Christophe Peczynski, et al.
Bone Marrow Transplantation|March 18, 2018
Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinibLotte van der Wagen, Liane Te Boome, Marleen Schiffler, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 23, 2008
Hepatitis C virus immune escape via exploitation of a hole in the T cell repertoireMatthias Wölfl, Alleluiah Rutebemberwa, Timothy Mosbruger, et al.
Pageof 26